Inventor · disambiguated record
Rohini D'Souza
Also filed as: D'SOUZA ROHINI
4 granted patents·9 pending applications·2 citations·filing 2004–2025
66Inventor score
Top patents by PatentIndex Score
13 records- 0178US7968089B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 28, 2011·2 cites·34 claims
- 0271US2024050376A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0370US12029820B2Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·0 cites·32 claims
- 0465US2025248942A1Sustained Release Compositions of 4-AminopyridineMERZ PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 0564US9528102B2Proteoglycan degrading mutants for treatment of CNSACORDA THERAPEUTICS INC·Filed 2014·Granted Dec 27, 2016·0 cites·6 claims
- 0664US2021085614A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0763US2022323362A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0862US2020253880A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0959US2017137799A1Proteoglycan degrading mutants for treatment of cnsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1058US2018344649A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1157US7429375B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2004·Granted Sep 30, 2008·0 cites·12 claims
- 1254US2020108016A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1353US2011250631A1Proteoglycan degrading mutants for treatment of cnsGRUSKIN ELLIOTT A·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rohini D'Souza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →